November 27, 2014 9:54 AM ET

Pharmaceuticals

Company Overview of Symphony Evolution, Inc.

Company Overview

Symphony Evolution, Inc., a biopharmaceutical company, develops therapeutics to treat cancer and diabetic nephropathy. It involves in the development of clinical programs, including XL647, a potent inhibitor of receptor tyrosine kinases (RTK); XL999 that inhibits RTKs implicated in the development and maintenance of tumor vasculature; and XL784, a small molecule compound for renal disease. The company was incorporated in 2005 and is based in Rockville, Maryland.

7361 Calhoun Place

Suite 325

Rockville, MD 20855

United States

Founded in 2005

Phone:

301-762-3148

Key Executives for Symphony Evolution, Inc.

Chief Executive Officer
Chief Financial Officer
Chief Scientific Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Secretory IgA, Inc. United States
Edusa Pharmaceuticals, Inc. United States
Chemwerth, Inc. United States
Amneal Pharmaceuticals, L.L.C. United States
Tharos Laboratories, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Symphony Evolution, Inc., please visit www.symphonyevolution.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.